Ginkgo Bioworks Holdings, Inc. (DNA) Investor Relations Documents

Ginkgo Bioworks Holdings, Inc. (DNA) investor relations documents from the company's IR site: 1 presentation, 16 press releases; latest deck 2026-08-05. Read in-app with summaries. First-party data.

Presentation: Ginkgo Bioworks Q2 2026 update reports $302M cash reserves and a focus on investing in Autonomous Labs, aiming to decommission manual benches and secure new sales for the platform.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-05	Earnings deck	Presentation
2026-08-05	Press release	Ginkgo Bioworks Q2 2026 Results
2026-08-05	Press release	Press Release
2026-04-30	Press release	Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation
2026-03-02	Press release	Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
2026-02-26	Press release	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offering
2026-02-19	Press release	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
2026-02-18	Press release	Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultur
2026-02-05	Press release	Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientifi
2026-01-13	Press release	Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
2025-12-22	Press release	Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
2025-05-27	Regulatory report	Notice of Pendency and Proposed Settlement of Derivative Actions
	Press release	Ginkgo Bioworks Acquires Adaptive Laboratory Evolution Company Altar
	Press release	Vertex CEO Reshma Kewalramani, MD to join Ginkgo Bioworks Board of Directors
	Press release	New Hampshire Department of Health and Human Services Brings Pooled Testing to K-12 Classrooms in Partnership with Conce
	Press release	Ginkgo Bioworks Selected to Provide Pooled COVID-19 Testing for Massachusetts K-12 Schools
	Press release	Dylan George joins Ginkgo Bioworks to grow the company’s global biosecurity efforts
	Press release	Bolt Threads to Leverage Ginkgo Bioworks’ Platform for Commercial Strain Optimization of b-silk™ Protein

DNA overview · DNA earnings · DNA financials · DNA KPIs · DNA ownership · DNA peers · DNA filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.